A circulating hormone measure may not mirror every tissue response. This rat experiment measured bone growth directly rather than inferring it solely from a blood marker. Primary study
Reported experiment
Adult female rats received ipamorelin over 15 days. Fluorescent labeling of the tibia showed increased longitudinal growth, while total circulating IGF-I and selected bone-turnover markers did not change. A subsequent ipamorelin challenge produced a modestly reduced growth-hormone response, whereas the response to GHRH was unchanged. Primary report
Our appraisal: do not force every endpoint into one story
The absence of a detected circulating change does not prove that a pathway played no role locally or at an unmeasured time. Conversely, a tissue response should not be used to claim that an unobserved blood-marker increase must have occurred. The measurements should be reported as they stand.
Challenge tests address responsiveness under a specified stimulus. They are not the same as spontaneous hormone secretion across the day. A smaller response to one challenge and an unchanged response to another can motivate a pathway-specific hypothesis, but do not establish every step of the adaptation mechanism.
The anatomical and species boundary is particularly important for height claims. Growth-plate behavior in a rat model cannot be translated directly into increased adult human height. Nor does it establish efficacy or safety in children with a growth disorder; those require appropriately designed clinical studies.
Full review should inspect animal maturity, labeling intervals, measurement blinding, sample sizes, and hormone-sampling schedules. Bone turnover, longitudinal growth, total bone mass, and strength should remain distinct endpoints. This study contributes to secretagogue physiology and skeletal growth research, not a validated height-enhancement intervention.
Frequently asked questions
Was longitudinal growth measured directly?
Yes, through fluorescent bone labeling.
Did circulating total IGF-I clearly increase?
No change was reported.
Does that exclude every local IGF-related mechanism?
No.
Were both provocative hormone responses identical?
No.
Is a challenge test equivalent to daily hormone output?
No.
Does the study establish increased adult human height?
No.
What must precede pediatric clinical claims?
Direct clinical evidence with appropriate growth and safety outcomes.